Medtronic, ZimVie and Zimmer Biomet all saw a decrease in revenue and sales in the second or third quarter of 2022.
Medtronic reported $7.6 billion in second quarter revenue, a 3 percent dip in reported revenue.
ZimVie reported a third-quarter revenue of $213.3 million. Its net sales were down 10.6 percent year over year. Its third-party spine sales also decreased 16.4 percent year over year.
Zimmer Biomet saw a less than one percent decrease in third quarter sales. Its net sales were down 0.9 percent from the same period last year.